Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Literature DB >> 9708239

Clinical impact of bone and calcium metabolism changes in sarcoidosis.

G Rizzato¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Calcitriol
Calcium

Year: 1998 PMID： 9708239 PMCID： PMC1745206 DOI： 10.1136/thx.53.5.425

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

59 in total

1. ON THE ABNORMAL CALCIUM ABSORPTION IN SARCOIDOSIS. EVIDENCE FOR INCREASED SENSITIVITY TO VITAMIN D.

Authors: N H BELL; J R GILL; F C BARTTER
Journal: Am J Med Date: 1964-04 Impact factor: 4.965

2. The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate.

Authors: F ALBRIGHT; E L CARROLL; E F DEMPSEY; P H HENNEMAN
Journal: J Clin Invest Date: 1956-11 Impact factor: 14.808

3. Catalytic activity of partially purified renal 25-hydroxyvitamin D hydroxylases from vitamin D-deficient and vitamin D-replete rats.

Authors: M Warner
Journal: J Biol Chem Date: 1982-11-10 Impact factor: 5.157

4. Sarcoidosis of bone.

Authors: E Neville; L S Carstairs; D G James
Journal: Q J Med Date: 1977-04

5. Studies of 47-Ca metabolism in sarcoidosis: evidence for increased sensitivity of bone to vitamin D.

Authors: N H Bell; F C Bartter
Journal: Acta Endocrinol (Copenh) Date: 1967-01

6. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors: N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal: J Clin Invest Date: 1979-07 Impact factor: 14.808

7. Abnormal regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase activity by calcium and calcitonin in renal cortex from hypophosphatemic (Hyp) mice.

Authors: M Fukase; L V Avioli; S J Birge; L R Chase
Journal: Endocrinology Date: 1984-04 Impact factor: 4.736

8. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

Authors: J S Adams; O P Sharma; M A Gacad; F R Singer
Journal: J Clin Invest Date: 1983-11 Impact factor: 14.808

9. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

Authors: S E Papapoulos; T L Clemens; L J Fraher; I G Lewin; L M Sandler; J L O'Riordan
Journal: Lancet Date: 1979-03-24 Impact factor: 79.321

10. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.

Authors: A Struys; A A Snelder; H Mulder
Journal: Am J Med Date: 1995-09 Impact factor: 4.965

17 in total

1. Case Study: Cardiac sarcoidosis resolved with Mycobacterium avium paratuberculosis antibiotics (MAP).

Authors: Branko G Celler
Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 2018-04-28 Impact factor: 0.670

Review 2. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors: Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal: Endocr Rev Date: 2016-09-02 Impact factor: 19.871

Review 3. Bone health issues in sarcoidosis.

Authors: Nadera J Sweiss; Elyse E Lower; Peter Korsten; Timothy B Niewold; Murray J Favus; Robert P Baughman
Journal: Curr Rheumatol Rep Date: 2011-06 Impact factor: 4.592

Clinical impact of bone and calcium metabolism changes in sarcoidosis.

1. ON THE ABNORMAL CALCIUM ABSORPTION IN SARCOIDOSIS. EVIDENCE FOR INCREASED SENSITIVITY TO VITAMIN D.

2. The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate.

3. Catalytic activity of partially purified renal 25-hydroxyvitamin D hydroxylases from vitamin D-deficient and vitamin D-replete rats.

4. Sarcoidosis of bone.

5. Studies of 47-Ca metabolism in sarcoidosis: evidence for increased sensitivity of bone to vitamin D.

6. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

7. Abnormal regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase activity by calcium and calcitonin in renal cortex from hypophosphatemic (Hyp) mice.

8. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

9. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

10. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.

1. Case Study: Cardiac sarcoidosis resolved with Mycobacterium avium paratuberculosis antibiotics (MAP).

Review 2. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Review 3. Bone health issues in sarcoidosis.

4. [Renal manifestations in rheumatic diseases].

5. Bone density is normal and does not change over 2 years in sarcoidosis.

6. Osseous sarcoid with lytic lesions in skull.

7. Long-term hypervitaminosis D-induced hypercalcaemia treated with glucocorticoids and bisphosphonates.

8. Hyercalcemia induced by interferon therapy in chronic hepatitis C.

9. Randomised controlled trial of vitamin D supplementation in sarcoidosis.

10. Hypercalcemia in a male-to-female transgender patient after body contouring injections: a case report.